Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Wegovy can give you headaches. Headache is a recognised side effect of semaglutide, listed in the official prescribing information and reported by a meaningful proportion of people in clinical trials. It tends to appear early in treatment or after a dose increase, and for most people it settles within a week or two. That said, not every headache on Wegovy is caused by the medicine itself — dehydration from nausea, reduced food intake and disrupted sleep can all play a role. Because Wegovy is a prescription-only medicine, a GPhC-registered prescriber reviews your full health picture before treatment starts, including any relevant symptoms you already experience.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's a frustrating experience: you start treatment hoping to feel better, and within the first few days you're reaching for paracetamol. Many people find headaches cluster around the first week or two of a new dose. The most likely explanation isn't the medicine acting directly on your brain, it's the cascade of adjustments happening in your body all at once.
Semaglutide slows gastric emptying and suppresses appetite significantly, which means many people eat and drink less than usual, sometimes without fully realising. If your fluid intake drops, a tension headache is an almost inevitable result. Nausea and vomiting (the most frequently reported Wegovy side effects) compound this by causing you to lose fluids before they're absorbed. The NHS medicines page for semaglutide lists headache alongside the common gastrointestinal symptoms, which is a useful reference to keep to hand.
Disrupted eating patterns matter too. If you're eating much less (or skipping meals entirely because nothing appeals) blood-sugar dips can cause a dull, persistent headache. This is separate from any hypoglycaemia risk; it's simply the effect of lower carbohydrate intake arriving suddenly rather than gradually. Our page on Wegovy side effects covers the full picture if you want the broader context.
The reassuring pattern: in most cases these headaches ease as the body adjusts over one to two weeks. They often return briefly when you move to the next dose step, then settle again.
It's a fair question, and the honest answer is: probably both. Semaglutide does have a direct physiological effect, GLP-1 receptors are present in the brain as well as the gut, and changes in appetite signalling, gastric motility and fluid balance can all influence how the head feels. Headache appears in the SmPC not as a rare finding but as a reported adverse effect.
At the same time, the indirect routes matter just as much in practice. Dehydration is the one worth addressing first, because it's the most controllable. Aiming for roughly six to eight glasses of water a day (consciously, because thirst signals can dampen when appetite does) makes a genuine difference for many people. Small, frequent meals rather than skipped ones can also smooth out the blood-sugar fluctuations that make headaches worse.
If you're curious whether your headache is coming from the medicine or something else entirely, tracking when the headaches occur relative to your injection day can help. Many people find they peak around 24–48 hours after the weekly dose. A pattern like that points clearly toward the medicine's pharmacology rather than lifestyle factors alone. For a closer look at how the headache and semaglutide connection plays out over the course of treatment, that page goes into more detail.
One thing worth noting: if you were prone to migraines before starting Wegovy, it's worth flagging this to your prescriber. Triggers can interact in unpredictable ways, and having that history on record matters.
Most Wegovy headaches are uncomfortable rather than dangerous, and they respond to standard over-the-counter pain relief, rest and good hydration. But certain features should prompt you to seek medical help without waiting.
Get medical attention promptly if your headache is sudden and severe (described by medical teams as "thunderclap", meaning it reaches peak intensity within seconds) or if it arrives alongside changes to your vision, confusion, weakness on one side of your body, or an unusually stiff neck. These features are not typical of a GLP-1 side effect and need assessment that same day.
Also speak to a doctor if headaches persist beyond two weeks without any improvement, or if they're worsening rather than settling as you move through a dose. Very persistent headaches can occasionally be linked to blood-pressure changes, and your prescriber will want to rule that out.
The full guide on Wegovy-related headaches covers management strategies and the distinction between types, and if you want a broader overview of how Wegovy and headaches relate across the full course of treatment, that page brings together the key patterns and practical advice. You can also report any suspected side effect through the MHRA's Yellow Card scheme, this helps regulators monitor real-world safety data for newer medicines, and your report counts even if you're not certain the medicine caused it.
If you have questions about your own symptoms, our aftercare team is available seven days a week.
Headaches, and how you typically respond to medicines, are the kind of detail that belongs in a prescriber's hands before treatment begins) not something to figure out alone afterwards. When you start treatment through nume, a GPhC-registered Independent Prescriber reads your full consultation the same day. That review isn't a box-ticking exercise; it's a clinician checking whether semaglutide is the right choice for you and flagging anything in your history that might affect how you experience the medicine.
Wegovy is a prescription-only medicine, suitability is determined by a prescriber, not by a symptom checker or a sales page. If you're considering it, the most useful first step is a proper clinical assessment. Our prescribers discuss likely side effects, including headaches, and explain what to watch for as part of every consultation. You can check your eligibility and start that conversation without commitment. If you want to understand more about how Wegovy works before you do, our Wegovy overview page is a good place to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.